Skip to main content

Codiak BioSciences, Inc.

CDAKDelisted May 2, 2023
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001659352

Codiak BioSciences, Inc. was delisted on May 2, 2023; its insiders filed their last Form 4 on Mar 30, 2023; 27 institutions reported holding it in 13F filings for Q1 2023, worth $1.44M in total; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding Codiak BioSciences, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of CDAK: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders4948−1
Shares11.7M17.4M+5.66M (+48.2%)
Value$33.9M$13.6M−$20.3M (−59.9%)

New holders (11)

Institutions that held Codiak BioSciences, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to CDAK in Q3 2022
InstitutionSharesValue% of portfolio
Armistice Capital, LLC1,000,000$782.0K0.02%
Alaska Permanent Fund Corp980,194$767.0K0.01%
Alyeska Investment Group, L.P.732,593$573.0K0.01%
Empery Asset Management, LP237,943$186.0K1.11%
Prudential Financial Inc36,600$29.0K0.00%
Acadian Asset Management LLC23,915$18.0K0.00%
National Asset Management, Inc.14,172$12.0K0.00%
Man Group plc15,198$12.0K0.00%
Warberg Asset Management LLC10,000$8.00K0.00%
Royal Bank of Canada148$00.00%
China Universal Asset Management Co., Ltd.213$00.00%

Sold out (12)

Institutions that held Codiak BioSciences, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of CDAK in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Oracle Investment Management Inc463,998$1.34M
Franklin Resources Inc330,000$950.0K
Bank of Montreal69,500$288.0K
Goldman Sachs Group Inc21,853$63.0K
Private Advisor Group, LLC10,959$32.0K
ETF Managers Group, LLC7,107$26.0K
Simplex Trading, LLC405$1.00K
Barclays PLC140$0
New York State Common Retirement Fund132$0
Credit Suisse AG8$0
Captrust Financial Advisors142$0
Capital Advisors, Ltd. LLC12$0